Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53 - Wikidata - awgldk - TriplyDB

Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53

Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53

http://www.wikidata.org/entity/Q28198423

about

sameAs

Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3 Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL Ell3 enhances differentiation of mouse embryonic stem cells by regulating epithelial-mesenchymal transition and apoptosis dELL, a drosophila homologue of transcription elongation factor ELL (Eleven-nineteen Lysine rich Leukemia), is required for early development.Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53 ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells.Mutational analysis of an RNA polymerase II elongation factor in Drosophila melanogaster p53 Interacts with RNA polymerase II through its core domain and impairs Pol II processivity in vivo.Common themes in the pathogenesis of acute myeloid leukemia.The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells Human p53 interacts with the elongating RNAPII complex and is required for the release of actinomycin D induced transcription blockage.Transcriptional regulation by p53.Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival.Anti-angiogenesis effect of 3'-sulfoquinovosyl-1'-monoacylglycerol via upregulation of thrombospondin 1.Involvement of pRB-related p107 protein in the inhibition of S phase progression in response to genotoxic stress.Regulation of Eaf2 in mouse lens cells apoptosis induced by ultraviolet radiation p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled.A comprehensive and high-resolution genome-wide response of p53 to stress.Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia.Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2.

P2860

Q22254564-1DE4ED6F-EFAB-4CBB-A9AF-A86D5F22DE72 Q24675588-02F5AB29-1F04-4586-A4D5-0C821345C7D4 Q28590241-D2F03E75-A13F-4A77-8718-0AD83DBC7936 Q31049852-3A40DE3E-0986-4070-9314-2D3DCE26A285 Q33604141-734D1379-BAF9-4797-B92E-5964BA3960BD Q33802059-E38EEA23-715D-42DF-ADB2-1837DF8EF1D8 Q33925022-06CE2DEE-2D68-4A78-9E9E-9CB1FDEE51F3 Q33988333-0B8FC2E3-3BC4-4BFE-8667-1D39ABCC66F6 Q34405458-377419B8-CDE0-4408-969C-B0BAA83B0BB1 Q35888903-02E925BA-5723-4AA1-AB08-00935FD22CF6 Q37301786-1C13FF34-35B5-492D-82D0-8069EE7E8DD5 Q37593366-38970E56-BDF3-48D9-BCAE-EFC148F645F3 Q37777267-30C915C3-B77D-4555-9D6A-21F4DAD9F706 Q38303471-F33543A4-D97D-4A05-AD49-D3309B953D05 Q39225511-0FBE54C3-C10C-42B2-B371-6F738FEE20B0 Q40816996-8F039697-DD44-4084-9D52-19107FFF605A Q41619942-BAA35E83-654B-4637-8CCD-BFA7C32D303C Q42098836-7D7FD87B-F116-4714-8AF5-7485CBE1D733 Q42752108-E509697B-89E5-47AA-9BE9-09B66DB7D08D Q43099231-E40D686C-E376-4993-A21C-EF4C48BB698D Q46891002-35B53A44-008D-436C-ACF0-E37249CB9844 Q50453702-BDE87E77-64A5-4C67-90A3-0C12E29277FE Q50988424-694DD628-5FD7-4348-8187-6BE7D8944EA3

P2860

Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53

http://www.wikidata.org/entity/Q28198423

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Physical interaction and funct ...... elongation factor ELL and p53

@ast

Physical interaction and funct ...... elongation factor ELL and p53

@en

Physical interaction and funct ...... elongation factor ELL and p53

@nl

type

label

Physical interaction and funct ...... elongation factor ELL and p53

@ast

Physical interaction and funct ...... elongation factor ELL and p53

@en

Physical interaction and funct ...... elongation factor ELL and p53

@nl

prefLabel

Physical interaction and funct ...... elongation factor ELL and p53

@ast

Physical interaction and funct ...... elongation factor ELL and p53

@en

Physical interaction and funct ...... elongation factor ELL and p53

@nl

P1433

Q28198423-F5E235E5-BF25-4487-90D7-23B3315716CE

P1476

Q28198423-1F1950E2-0498-46E2-A460-77031E598E73

P2093

Q28198423-31C7DE51-5E2C-43F3-A8A0-E0894E9FA9AD

Q28198423-38AAE1BE-F071-4147-A4AD-84A2B1623864

Q28198423-70EEF410-546F-4A73-BFE0-F6263AB788E6

Q28198423-7530F292-D6FA-4990-A3B2-60B37EAF1FDD

Q28198423-7C82AB05-E1E7-4C8F-9C4D-C2312C96AFCB

Q28198423-804127A0-5F7D-4873-A118-3FF40ED833E4

Q28198423-C1E29A03-8A6F-4E96-BA53-1DF636ECFBD4

P2860

Q28198423-119643A7-4FBE-4453-9CAB-C77A7F1B6788

Q28198423-1202A2D5-AD79-4C4F-82D9-F246CBA63FA0

Q28198423-1670258D-D5EC-425F-B3F6-FBE2567AF992

Q28198423-175B1BBB-DDA9-4B43-9183-882FC9C414BF

Q28198423-1E3FD9F8-BCEA-49A5-AEB8-B9650CCD1F9C

Q28198423-207CDAEF-164E-4019-B924-D03C70E7EB68

Q28198423-21A12D50-F1D3-4E9F-A8E7-57E305ECF5F8

Q28198423-2290888C-CE20-423D-8F52-0D6B9C17051F

Q28198423-2AAFA2DA-4459-4269-8D7A-3813496D6652

Q28198423-2D70CA09-F9EF-44B1-A8B2-41BCE7996FF3

P304

Q28198423-1773F1EC-2F28-4E42-BCEE-733118D8BCDA

P31

Q28198423-731A7DAC-CBAB-43CD-9A85-4E4A09B3151B

P3181

Q28198423-94AE5F5E-88DA-4180-8553-70B72443A4E6

P356

Q28198423-B0C27617-3E9F-4A7D-BB86-3742F2690CE8

P407

Q28198423-17E7FEBF-7F54-4BBB-B3C4-67FFDA3EB80E

P433

Q28198423-651E3B8C-4F56-41EB-8716-F105628AD295

P478

Q28198423-340360D7-D091-459B-AFB8-1AD18D746F1A

P577

Q28198423-04E4882A-3836-46D2-ABEB-B4E0432F0EB1

P698

Q28198423-50A47A0F-3CCA-4EDF-AFBA-AC744F633E78

P3181

P356

JBC.274.24.17003

P1433

Journal of Biological Chemistry

P1476

Physical interaction and funct ...... elongation factor ELL and p53

@en

P2093

K Koike

http://www.w3.org/2001/XMLSchema#string

M Hatakeyama

http://www.w3.org/2001/XMLSchema#string

N Shinobu

http://www.w3.org/2001/XMLSchema#string

T Aso

http://www.w3.org/2001/XMLSchema#string

T Ito

http://www.w3.org/2001/XMLSchema#string

T Kondo

http://www.w3.org/2001/XMLSchema#string

T Maeda

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

Wild-type p53 binds to the TATA-binding protein and represses transcription

Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

An RNA polymerase II elongation factor encoded by the human ELL gene

Mdm2 promotes the rapid degradation of p53

Inhibition of transcription elongation by the VHL tumor suppressor protein

Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

P304

17003-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4912636

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.274.24.17003

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

274

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10358050

http://www.w3.org/2001/XMLSchema#string